My personal and professional experiences have convinced me that better communication and collaboration between the scientific community, health-care professionals and the public - including individuals affected by schizophrenia and their families - is urgently needed, to improve people's lives.
Scientists still know very little about this complex disorder, the study of which is chronically underfunded. We don't understand all of its biological underpinnings. We don't have biomarkers to diagnose it.
One standard therapy, haloperidol, is more than 50 years old. It has side effects such as involuntary motor movements.
Collection
[
|
...
]